PENNYQHealthcare·Medical Devices#13 in industry

Penumbra, Inc.

-8.7% · 90d

$327.98

-1.91 (-0.58%)

After-Hours $327.98(+0.00)

News

(2)

April 2026

Apr 23, 20264 days ago425Healthcare

Penumbra Inc — 425 Filing

PENPenumbra Inc

# 📄 What This Document Is This is a **Form 425 filing** with the SEC. Think of it as a public disclosure of communication related to a major business deal. In this case, Penumbra is letting the world know it's sending final voting reminders to its shareholders about the planned merger with Boston S

Read summaryView on SEC EDGAR

Apr 22, 20265 days ago425Healthcare

PEN Shareholders Vote May 6 on Boston Scientific Acquisition

PENPenumbra Inc

# 🧾 What This Document Is This is a transcript from **Boston Scientific's Q1 2026 earnings call**, filed with the SEC as a Form 425. This filing type is used when companies want to share information about "business combinations"—in this case, their planned **acquisition of Penumbra, Inc.** Think of

Read summaryView on SEC EDGAR

Key Data

Market Cap$12.87B

Open$329.91

Prev Close$329.89

Day Range$327.75 – $331.80

52W Range$221.26 – $362.41

Volume242,843

P/E (TTM)72.56

EPS$4.52

Dividend Yield—

Beta0.84

Profit Margin12.66%

Revenue Growth22.10%

Price Target$365.79(+11.5%)

Next Earnings2026-04-27(0d)

Analyst Ratings

Buy17 analysts

Buy 4Hold 13Sell 0

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Healthcare · Medical Devices

4,700 employees

www.penumbrainc.com